Drug policy of Portugal
Drug policy of Portugal
The Drug policy of Portugal is notable for its decriminalization of the possession of all drugs for personal use. Implemented in 2001, this policy was a response to the country's drug crisis in the 1990s. The primary objective of Portugal's drug policy is to treat drug use as a public health issue rather than a criminal one. This article provides an overview of the key elements of Portugal's drug policy, its implementation, and its impacts.
Background
In the late 20th century, Portugal faced a severe drug crisis. The country had one of the highest rates of HIV/AIDS among drug users in Europe. The crisis was exacerbated by the lack of effective drug policies and the criminalization of drug users, which hindered individuals from seeking help due to fear of prosecution.
Decriminalization
In July 2001, Portugal took a radical step by decriminalizing the possession of all drugs for personal use. Under the new law, drug possession for personal use is treated as an administrative offense, similar to a traffic violation. The law defines "personal use" as the amount of a drug that one person can consume over a 10-day period, with specific quantities outlined for different substances.
Drug Commissions
A key component of Portugal's drug policy is the creation of "Dissuasion Commissions" or "Commissions for the Dissuasion of Drug Addiction" (CDTs). These commissions are multidisciplinary panels consisting of legal, health, and social work professionals. Individuals caught with drugs for personal use are referred to these commissions, which assess the individual's drug use and determine the most appropriate response. This can range from no penalty at all to warnings, fines, or treatment recommendations.
Impact
The impact of Portugal's drug policy has been the subject of much international attention and debate. Studies have shown a decrease in new HIV infections among drug users, a reduction in drug-related deaths, and a decrease in the overall prevalence of drug use among adolescents. Furthermore, the decriminalization has led to an increase in the number of people seeking treatment for drug addiction.
Criticism and Challenges
Despite its successes, Portugal's drug policy has faced criticism. Some argue that decriminalization may send a message that drug use is acceptable, potentially leading to increased consumption. Others point to the ongoing challenges of addressing drug trafficking and the need for continuous investment in treatment and harm reduction services.
Conclusion
Portugal's approach to drug policy, with its focus on decriminalization and treating drug use as a public health issue, represents a significant shift from traditional drug enforcement strategies. While challenges remain, the positive outcomes observed in Portugal provide valuable insights for other countries grappling with similar issues.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD